AXONIS Therapeutics
PrivateLast Round
Series A
Oct 30, 2024
Total Funding Raised
$132.7M
Company Overview
Axonis Therapeutics is a biotechnology company focused on developing therapies for neurological disorders that target critical mediators of inhibition in the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AXONIS Therapeutics Comps
Public and private peers based on sector, stage, and business model.
AXONIS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 30, 2024 | ||||
| Seed | Jul 14, 2021 | ||||
| Seed | May 28, 2020 |
Key People
Founding team and executive leadership
AXONIS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| MRL Ventures Fund | Series A |
| MRLV | Series A |
| SCI Ventures | Series A |
| CURE Epilepsy | Grant |
| Perceptive Advisors | Series A |
| Acks | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Translating discoveries from Boston Children's Hospital, Harvard, and Laval University.
- Jul 3, 2025
Grew 3D brain organoids in space to test new neurological drugs.
AXONIS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AXONIS Therapeutics's valuation, stock price, and market status.
